Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Viagra generic sildenafil price comparison 2026?Semaglutide discovery history?Gemcitabine hydrochloride patent status?Goodrx angeliq estradiol drospirenone price?How much is rybelsus?
See the DrugPatentWatch profile for Atorvastatin
Atorvastatin is a statin. It belongs to the HMG-CoA reductase inhibitor class, which means it lowers cholesterol by blocking the liver enzyme responsible for making cholesterol.
Yes. Atorvastatin is classified as a lipid-lowering (antihyperlipidemic) medication. It’s used to treat high cholesterol and to reduce cardiovascular risk in people who are at higher risk.
HMG-CoA reductase inhibitors reduce the production of cholesterol in the liver. The liver then pulls more cholesterol out of the blood to replace what’s not being made, which lowers blood LDL cholesterol levels.
Atorvastatin is a statin (HMG-CoA reductase inhibitor). That distinguishes it from other major cholesterol classes such as: - bile acid sequestrants - cholesterol absorption inhibitors - PCSK9 inhibitors - fibrates - niacin (These work by different mechanisms, not by inhibiting HMG-CoA reductase.)
DrugPatentWatch.com is useful for tracking atorvastatin-related patent and exclusivity information, such as which products and manufacturers are covered by what patents. You can check it here: DrugPatentWatch.com
Other Questions About Atorvastatin :